Early Screening System Detects Diabetic Retinopathy
By HospiMedica International staff writers Posted on 12 May 2014 |
A novel end-to-end retinal screening solution quickly identifies and diagnoses patients with diabetic retinal disease.
The iConnect Retinal Screening solution enables providers to efficiently capture retinal images through an automated camera, reducing the need for staff to receive specialty training. Images are transferred via the cloud to the Merge Eye Care PACS reading center, an interoperable, subscription-based service where trained technicians and pathologists bear the responsibility of identifying, diagnosing, and delivering results. The results are then transmitted via the iConnect Network to the provider's electronic health record (EHR) system to allow for timely, customized care plans.
The solution thus streamlines operational workflow, reduces financial costs, and enables of the improvement of clinical care quality by leveraging the iConnect Cloud Archive infrastructure. The first phase of the solution will enable automated, early screening detection of diabetic retinopathy, an increasingly common complication of diabetes and one of the leading causes of visual impairment and blindness among working-aged adults. The iConnect Retinal Screening solution, Eye Care PACS, and iConnect Network are services of Merge Healthcare (Chicago, IL, USA).
“Diabetes affects more than 347 million people globally, and it's estimated that one out of every five US healthcare dollars is spent on this disease,” said Steven Tolle, chief strategy officer at Merge Healthcare. “By creating a solution that addresses both patient and provider knowledge gaps, we're helping providers more easily diagnose and treat not only diabetes, but retinal disease as a whole. Patients, in turn, are empowered with faster treatment plans which can reduce the risk of negative side effects.”
“By leveraging our existing cloud technology, Merge customers will be able to enhance care for the large number of diabetic patients in our nation,” said Justin Dearborn, CEO of Merge Healthcare. “Our deep expertise with other specialty screenings, such as mammography, cervical and cardiology, positions us well to help in the eye care market. This new, end-to-end solution will be a win-win for patients and providers, enabling a detrimental disease to be diagnosed and treated earlier having the additional benefit of reducing short- and long-term healthcare costs.”
The iConnect Network allows hospitals, providers, and imaging centers to exchange imaging information electronically with community physicians that are connected to Health Information Exchanges (HIEs) or electronic health records (EHR) networks, such as the Surescripts (Arlington, VA, USA) Clinical Network Services (CNS).
Related Links:
Merge Healthcare
Surescripts
The iConnect Retinal Screening solution enables providers to efficiently capture retinal images through an automated camera, reducing the need for staff to receive specialty training. Images are transferred via the cloud to the Merge Eye Care PACS reading center, an interoperable, subscription-based service where trained technicians and pathologists bear the responsibility of identifying, diagnosing, and delivering results. The results are then transmitted via the iConnect Network to the provider's electronic health record (EHR) system to allow for timely, customized care plans.
The solution thus streamlines operational workflow, reduces financial costs, and enables of the improvement of clinical care quality by leveraging the iConnect Cloud Archive infrastructure. The first phase of the solution will enable automated, early screening detection of diabetic retinopathy, an increasingly common complication of diabetes and one of the leading causes of visual impairment and blindness among working-aged adults. The iConnect Retinal Screening solution, Eye Care PACS, and iConnect Network are services of Merge Healthcare (Chicago, IL, USA).
“Diabetes affects more than 347 million people globally, and it's estimated that one out of every five US healthcare dollars is spent on this disease,” said Steven Tolle, chief strategy officer at Merge Healthcare. “By creating a solution that addresses both patient and provider knowledge gaps, we're helping providers more easily diagnose and treat not only diabetes, but retinal disease as a whole. Patients, in turn, are empowered with faster treatment plans which can reduce the risk of negative side effects.”
“By leveraging our existing cloud technology, Merge customers will be able to enhance care for the large number of diabetic patients in our nation,” said Justin Dearborn, CEO of Merge Healthcare. “Our deep expertise with other specialty screenings, such as mammography, cervical and cardiology, positions us well to help in the eye care market. This new, end-to-end solution will be a win-win for patients and providers, enabling a detrimental disease to be diagnosed and treated earlier having the additional benefit of reducing short- and long-term healthcare costs.”
The iConnect Network allows hospitals, providers, and imaging centers to exchange imaging information electronically with community physicians that are connected to Health Information Exchanges (HIEs) or electronic health records (EHR) networks, such as the Surescripts (Arlington, VA, USA) Clinical Network Services (CNS).
Related Links:
Merge Healthcare
Surescripts
Latest Health IT News
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
- New Self-Learning AI-Based Algorithm Reads Electrocardiograms to Spot Unseen Signs of Heart Failure
- Autonomous Robot Performs COVID-19 Nasal Swab Tests
- Statistical Tool Predicts COVID-19 Peaks Worldwide
- Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
- Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
- Human Torso Simulator Helps Design Brace Innovations
- 3D Bioprinting Rebuilds the Human Heart